Jaundice

It is common for people with pancreatic cancer to experience jaundice.  Jaundice is a yellowing of the skin and eyes caused by excess bilirubin (a component of bile) in the blood.  A tumor in the head of the pancreas can cause narrowing of the bile duct and block the bile flowing from the gallbladder into the small intestine.  Blockage of the bile duct causes a buildup of bilirubin.  People with jaundice may also experience itchiness of the skin, abnormally dark urine and light or clay-colored stools.  If surgery to remove the tumor is possible, this can provide relief.  In some cases, a biliary bypass surgery may be performed to bypass the blocked bile duct.  For more information about bypass surgery, click here.  Otherwise, the jaundice is commonly treated by inserting a stent to keep the bile duct open.  For more information about stents, click here.

 

The information and services provided by the Pancreatic Cancer Action Network, Inc. are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. If you are ill, or suspect that you are ill, see a doctor immediately! The Pancreatic Cancer Action Network does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site. In addition, please note that any personal information you provide to the Pancreatic Cancer Action Network’s associates during telephone and/or email consultations may be stored in a secure database to assist the Pancreatic Cancer Action Network, Inc. in providing you with the best service possible. Portions of the constituent data stored in this database may be used to inform future programs and services of the Pancreatic Cancer Action Network, Inc., and may be provided in aggregate form to third parties to guide future pancreatic cancer research and treatment efforts. The Pancreatic Cancer Action Network, Inc. will not provide personal identifying information (such as your name or contact information) to third parties without your advanced written consent.  140306